Introduction

In the complex world of intellectual property, particularly in patent law, the procedural aspects of litigation can significantly influence the outcomes of cases. The recent ruling by the Delhi High Court in Helsinn Healthcare SA & Anr. v. Hetero Healthcare Limited CS(COMM)347/2024, I.A. 9522/2024 & I.A. 9523/2024 serves as a pivotal reference point for understanding how courts interpret timelines associated with written statements and the filing of replications. This case revolves around a patent infringement suit concerning Patent No. 426553. As with many legal matters, the focus is not solely on the substantive merits of the patent but also on procedural nuances that can ultimately dictate the course of legal disputes. The decision issued on September 26, 2025, by Hon'ble Mr. Justice Tejas Karia, tackles the critical question of when the countdown for filing a replication begins when faced with a belated written statement that requires condonation of delay. Understanding the implications of this ruling is crucial for legal practitioners, patent holders, and defendants alike. This blog will provide an in-depth analysis of the case's background, procedural posture, the court’s analysis, and the significance of the ruling.

Background and Procedural Posture

The procedural history of this case is essential in contextualizing the court's ruling.

1. Service of Summons: The defendant, Hetero Healthcare Limited, received summons on May 21, 2024.

2. Filing of Written Statement: The defendant filed its written statement on August 16, 2024, which was late and accompanied by an application seeking condonation for that delay.

3. Condonation Costs: When the written statement was taken on record on August 23, 2024, it was subject to a cost of 3,000 imposed by the Joint Registrar, paid by the defendant on August 30, 2024.

4. Replication Filing: The plaintiffs, Helsinn Healthcare, filed their replication on October 5, 2024.

The case raised significant questions regarding the applicable timelines under Rule 5, Chapter VII of the Delhi High Court (Original Side) Rules, 2018, specifically concerning the commencement of the 30-day window for filing a replication following the receipt of a written statement.

 Issues at Stake

The core issues evaluated by the court were:

1. Whether the 30-day timeline for filing a replication starts from the date of service of the belated written statement or from the date it is entered on record after the necessary condonation.

2. Whether the plaintiffs' replication filed on October 5, 2024, was within the permissible period established by the rules.

Governing Rules and Key Authorities

To understand the court's ruling, it is crucial to examine the governing rules and relevant case laws:

1. Rule 5, Chapter VII, DHC (Original Side) Rules, 2018: This rule states that replication must be filed within 30 days of receiving the written statement and may be extended by a further 15 days.

• Purposive line: SNS Products Pvt. Ltd. v. Ijaz Uddin (2023), Aroti Sarkar v. Ashok Sarkar (2023), Parmeet Singh Anand v. Subhash Chand Aggarwal (2024), Tata Sons v. Marvel Ltd. (2024), Neeraj Saran Srivastava v. Loudon Owen (2025), Bunch Microtechnologies v. Creator Economy Tech (2024).
• Strict line (distinguished on facts): Ram Swarup Lugani v. Nirmal Lugani (2019, 2020, SC 2021), Louis Dreyfus v. Nutralite Agro (2024), Delhi Gymkhana Club v. Col. Ashish Khanna (2024), and other decisions computing from service where WS was not contingent on condonation.

2.Prior Case Law: The court referenced several decisions interpreting this rule, distinguishing between two lines of cases: those favoring a purposive interpretation and those tied to a strict interpretation as applied to the facts of the case.

The court noted its reliance on the purposive line of decisions, which suggested that the replication period should begin from the time the belated written statement is taken on record.

Parties’ Contentions

Both parties presented compelling arguments around the issue:

Plaintiffs' Arguments:

1. The counting of days should begin once the written statement is taken on record, affirming that they submitted their replication within the permissible time frame.

2. They pointed to precedents where it was established that if a written statement requires condonation, the replication period should not start until the court officially acknowledges that statement.

 Defendant's Arguments:

1. The phrase “receipt of the written statement” triggered the timeline when the defendant served the plaintiff via email on August 16, creating a 30-day period that ended on September 30.

2. The defendant contended that the wording “but not thereafter” is an absolute bar once the time limit expires, making the plaintiffs' replication late and invalid.

 To know more about this, you can follow the below link:

The Court’s Analysis

In its judgment, the High Court provided a nuanced interpretation of the procedural rules:

1. Commencement of the Timeline: The court held that the period for filing a replication begins when the written statement is officially taken on record following the necessary condonation of delay. This interpretation aligns with previous Delhi High Court precedents, emphasizing flexible timelines to ensure substantive justice.

2. Rationale: It reasoned that if the written statement were not taken on record due to the refusal of condonation, there would be no requirement for a replication, thereby making it illogical to initiate the clock countdown at the time of service.

3. Conclusion: The court found that the plaintiffs filed their replication within the permissible 45-day maximum period. The 13-day delay was condoned, and the replication was thus accepted into the record.

Holding and Order

Ultimately, the court concluded that:

1.The replication period commenced when the written statement was taken on record on August 23, 2024.

2.The plaintiffs' replication on October 5, 2024, was within the legally permissible timeframe.

3.The delay of 13 days was condoned, and the replication was included on record.

The case was set for further proceedings on January 14, 2026.

Significance and Takeaways

This ruling is notable for several reasons:

1. Procedural Clarity: It clarifies the procedural rules regarding the filing of replications when dealing with belated written statements that require condonation. Legal practitioners should be vigilant in understanding that the commencement of the timeline can be contingent on the procedural status of documents.

2. Balancing Substantive and Procedural Justice: The decision emphasizes the court's commitment to ensuring that procedural rules do not hinder the pursuit of substantive justice. It promotes the idea that courts should adopt interpretations that facilitate fair adjudication rather than strictly penalizing parties for procedural missteps.

3. Implications for Future Cases: The ruling could influence how future disputes over the filing of written statements and replications are handled, potentially leading to increased leniency towards parties facing similar timing issues.

Conclusion

The Helsinn Healthcare SA & Anr. v. Hetero Healthcare Limited CS(COMM)347/2024, I.A. 9522/2024 & I.A. 9523/2024 case is a significant reference point for legal practitioners navigating the complex waters of patent law and procedural timelines. The court’s decision not only clarifies the legal framework surrounding the replication timelines but also stresses the importance of a purposive approach in interpreting procedural rules. Moving forward, this ruling could reshape litigation strategies in similar patent infringement suits and ensure that substantive rights are upheld, even in the face of procedural hurdles. For those involved in patent litigation or those advising clients in such matters, it is essential to remain informed about these nuances to effectively navigate the intricacies of the legal landscape.